Back
Altimmune Quote, Financials, Valuation and Earnings
Sponsored
ALT
Sponsored
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More
Sell
41
ALT
Altimmune
Last Price:
6.23
Seasonality Move:
22.36%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Altimmune Price Quote
$6.23
+0.08 (+1.22%)
(Updated: October 4, 2024 at 6:40 PM ET)
Altimmune Key Stats
Sell
41
Altimmune (ALT)
is a Sell
Day range:
$6.06 - $6.27
52-week range:
$2.09 - $14.84
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
955.08
P/B ratio:
2.87%
Volume:
1.1M
Avg. volume:
2.2M
1-year change:
152.25%
Market cap:
$437.4M
Revenue:
$426K
EPS:
$-1.64
How Much Does Altimmune Make?
Is Altimmune Growing As A Company?
Altimmune Stock Price Performance
What Is Altimmune 52-Week High & Low?
Altimmune Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Altimmune?
Is Altimmune Cash Flow Positive?
Altimmune Return On Invested Capital
Altimmune Earnings Date & Stock Price
-
What Is Altimmune's Stock Price Today?
A single share of ALT can be purchased today for 6.16 -
What Is Altimmune’s Stock Symbol?
Altimmune trades on the nasdaq under the ticker symbol: ALT -
When Is Altimmune’s Next Earnings Date?
The next quarterly earnings date for Altimmune is scheduled on November 7, 2024 -
When Is ALT's next ex-dividend date?
Altimmune's next ex-dividend date is January 20, 2017 -
How To Buy Altimmune Stock?
You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Altimmune Competitors
Altimmune Dividend Yield
-
What Is ALT Dividend Yield?
Altimmune’s dividend yield currently is 0% -
What Is Altimmune’s Payout Ratio?
Altimmune’s payout ratio is 0% -
When Did Altimmune Last Pay A Dividend?
The latest dividend pay date is October 4, 2024 -
What Is Altimmune’s Dividend Per Share?
Altimmune pays a dividend of $0.00 per share
Altimmune Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -1.45% |
Revenue: | -16.67% | 706.45% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 20.57 |
Upside from Last Price: | 234.22% |